SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK
38.06
08-يناير-25 15:45:00
15 متأخرة بدقائق
الأسهم
+0.63
+1.68%
نطاق اليوم
36.76 - 38.31
ISIN
N/A
المصدر
NASDAQ
-
Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults
29 أبريل 2022 19:00:38 بحسب Nasdaq GlobeNewswire
-
Supernus Reports Final Audited Fourth Quarter and Full Year 2021 Financial Results
13 أبريل 2022 15:11:14 بحسب Nasdaq GlobeNewswire
-
Supernus Provides Update on Filing of Annual Report and Reiterates Full Year 2022 Financial Guidance
04 أبريل 2022 16:00:00 بحسب Nasdaq GlobeNewswire
-
17 مارس 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Supernus to Participate in Annual Cowen Health Care Conference
02 مارس 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
Supernus Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results
28 فبراير 2022 15:05:01 بحسب Nasdaq GlobeNewswire
-
22 فبراير 2022 15:30:00 بحسب Nasdaq GlobeNewswire
-
22 فبراير 2022 07:00:01 بحسب Nasdaq GlobeNewswire
-
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
08 ديسمبر 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
Supernus Pharmaceuticals Targeted in Ransomware Incident
24 نوفمبر 2021 17:58:37 بحسب Nasdaq GlobeNewswire
-
Supernus Pharmaceuticals Completes Acquisition of Adamas Pharmaceuticals
24 نوفمبر 2021 08:12:51 بحسب Nasdaq GlobeNewswire
-
23 نوفمبر 2021 07:00:00 بحسب Nasdaq GlobeNewswire
-
Supernus to Participate in Annual Piper Sandler Healthcare Conference
18 نوفمبر 2021 07:00:02 بحسب Nasdaq GlobeNewswire
-
Supernus to Participate in Upcoming November Investor Conferences
10 نوفمبر 2021 15:05:03 بحسب Nasdaq GlobeNewswire
-
Supernus Announces Third Quarter 2021 Financial Results
03 نوفمبر 2021 15:01:01 بحسب Nasdaq GlobeNewswire
-
27 أكتوبر 2021 16:42:55 بحسب Nasdaq GlobeNewswire
-
Holly Robinson Peete Partners with Supernus to Raise Awareness During ADHD Awareness Month
20 أكتوبر 2021 07:00:02 بحسب Nasdaq GlobeNewswire
-
Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio
11 أكتوبر 2021 05:30:00 بحسب Nasdaq GlobeNewswire
-
Supernus Announces Qelbree™ sNDA for Adult Indication Accepted for Review by FDA
02 سبتمبر 2021 17:45:00 بحسب Nasdaq GlobeNewswire
-
Supernus to Participate in Upcoming September Investor Conferences
02 سبتمبر 2021 08:00:00 بحسب Nasdaq GlobeNewswire